Skip to main content
. 2010 Jan;12(1):39–50. doi: 10.1593/neo.91196

Figure 7.

Figure 7

The combinatorial effect of LLL12 and chemotherapy drugs, doxorubicin and gemcitabine. (A) MDA-MB-231 breast cancer cells were treated with LLL12 and doxorubicin individually and in combination. (B) HPAC pancreatic cancer cells were treated with LLL12 and gemcitabine individually and in combination. Cell viability was determined by MTT assay. A synergistic effect between LLL12 and doxorubicin or gemcitabine is indicated by an asterisk.